Sort
82,697 grants matching “vaccine development”
HIV/AIDS Vaccine and Antibody Development
$1,789,546John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$1,789,420Sampa Santra · Beth Israel Deaconess Medical Center · N01 · FY2016 · AI
Moffitt Skin Cancer SPORE
$1,789,062Vernon K. Sondak · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2017 · CA
Modulation of Biodefense Responses to Microbial Pathogens
$1,789,049Leo Lefrancois · University Of Connecticut Sch Of Med/Dnt · P01 · FY2010 · AI
Innate immune response to microbial infection
$1,788,479William Michael Nauseef · University Of Iowa · P01 · FY2011 · AI
A Synchrotron Radiation Structural Biology Resource
$1,788,047Aina E. Cohen · Stanford University · P30 · FY2025 · GM
Roswell Park Ovarian Cancer SPORE
$1,787,915Kirsten B Moysich · Roswell Park Cancer Institute Corp · P50 · FY2025 · CA
Innate immune response to microbial infection
$1,787,757William Michael Nauseef · University Of Iowa · P01 · FY2012 · AI
COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)
$1,787,600Thomas Denny · Duke University · N01 · FY2022 · AI
SARS Coronavirus: Inhibition of Entry
$1,787,597Kathryn V Holmes · University Of Colorado Denver · P01 · FY2008 · AI
Dys/Regulation of the Immune System in Autoimmunity
$1,787,416Richard A Flavell · Yale University · P01 · FY2006 · AI
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,787,333Carl H. June · University Of Pennsylvania · U19 · FY2011 · AI
Development of a nonhuman primate model of fetal Zika virus infection and disease
$1,786,954Koen K Van Rompay · University Of California At Davis · R21 · FY2017 · AI
Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS
$1,786,891Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Development testing of nucleic acid-based vaccine for HIV other indications
$1,786,891Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,786,679Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
HIV Preventive Vaccine Studies
$1,785,677Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Development of Fludase as an Anti-Influenza Agent
$1,785,659Mang Yu · Nexbio, Inc. · U01 · FY2008 · AI
Subcellular protein localization in B. subtilis
$1,785,089Kumaran Ramamurthi · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Antigen Processing And Presentation In The Intestine
$1,784,886Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Host Defense Against HIV-related Pulmonary Infections
$1,784,677Judd E Shellito · Lsu Health Sciences Center · P01 · FY2011 · HL
Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface
$1,784,658Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$1,784,002Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Natural History of HPV Infection in Men: The HIM Study
$1,783,975Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Development of a Vaccine for HIVAIDS: Cellular Immunity
$1,783,832Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA